Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NUP205 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | DROSHA | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | ARHGAP31 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | NFATC3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | CYB5R4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | ELF2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | GPR37L1 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.002 |
mRNA | HTATSF1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | GLIS2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | ST7 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |